Journal rankings · indicator year 2005
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Subfield ranking · 2005
Infectious Diseases journal rankings 2005
92 ranked journals · Subfield in Medicine
Infectious Diseases has 92 ranked journals in 2005. The median OJR rose 0.13 on 2004 to 0.90, below the world average of 1.00; Q1 starts at OJR 1.36. The top three are New England Journal of Medicine, Clinical Microbiology Reviews, and Annals of Internal Medicine.
Ranks and citation indicators: 2005. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2002–2004, the window the 2005 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields of Medicine (42)
- Surgery409
- Pulmonary and Respiratory Medicine172
- Public Health, Environmental and Occupational Health145
- Cardiology and Cardiovascular Medicine139
- Oncology120
- Infectious Diseases92
- Epidemiology91
- Psychiatry and Mental health87
- Radiology, Nuclear Medicine and Imaging81
- Neurology76
- Physiology72
- Endocrinology, Diabetes and Metabolism70
Show all 42 subfields
- Orthopedics and Sports Medicine54
- Pediatrics, Perinatology and Child Health52
- Dermatology49
- Hematology48
- Ophthalmology46
- Obstetrics and Gynecology41
- Rheumatology32
- Nephrology31
- Pharmacology31
- Complementary and alternative medicine25
- Reproductive Medicine25
- Emergency Medicine23
- Geriatrics and Gerontology19
- Otorhinolaryngology17
- Pathology and Forensic Medicine17
- Rehabilitation17
- Critical Care and Intensive Care Medicine13
- Immunology and Allergy12
- Hepatology9
- Genetics8
- Anesthesiology and Pain Medicine6
- Gastroenterology6
- Urology6
- Internal Medicine3
- Transplantation2
- Biochemistry1
- Family Practice1
- Anatomy0
- Health Informatics0
- Microbiology0
92 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2004. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2002–2004, the window the 2005 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2002–2004 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2000 to 2005. | Compare |
|---|---|---|---|---|---|---|---|
1New England Journal of MedicineMassachusetts Medical Society · United States | 9.67Q1 | 20.31 0.58 up from 2004 | 2,778 | 24% | — | ||
2Clinical Microbiology ReviewsAmerican Society for Microbiology · United States | 7.46Q1 | 12.90 0.30 up from 2004 | 132 | 100% | — | ||
3Annals of Internal MedicineAmerican College of Physicians · United States | 3.68Q1 | 6.67 0.28 down from 2004 | 1,441 | 1% | — | ||
4The Lancet Infectious DiseasesElsevier BV · Netherlands | 3.65Q1 | 6.66 1.07 down from 2004 | 309 | 9% | $7,280 | ||
5PLoS MedicineOAPublic Library of Science · United States | 2.77Q1 | 4.49no 2004 value | 49 | 100% | $6,460 | — | |
6Emerging infectious diseasesOACenters for Disease Control and Prevention · United States | 2.46Q1 | 4.92 0.58 down from 2004 | 1,220 | 100% | — | ||
7Clinical Infectious DiseasesOxford University Press · United States | 2.41Q1 | 5.49 0.28 up from 2004 | 2,352 | 29% | $4,763 | ||
8The Journal of Infectious DiseasesOxford University Press · United States | 2.32Q1 | 5.52no change | 1,861 | 39% | $4,763 | ||
9Reviews in Medical VirologyWiley · United Kingdom | 1.93Q1 | 5.53 0.45 up from 2004 | 111 | 12% | $4,880 | ||
10AIDSLippincott Williams & Wilkins · United Kingdom | 1.93Q1 | 5.15 0.12 up from 2004 | 1,498 | 6% | — | ||
11Journal of Water and HealthOAUWA Publishing | 1.92Q1 | 2.47 0.19 up from 2004 | 45 | 49% | — | ||
12AIDS Education and PreventionGuilford Press · United States | 1.85Q1 | 3.12 0.85 up from 2004 | 175 | 9% | — | ||
13Antimicrobial Agents and ChemotherapyOAAmerican Society for Microbiology · United States | 1.82Q1 | 4.65 0.07 up from 2004 | 2,309 | 99% | — | ||
14Microbes and InfectionElsevier BV · France | 1.76Q1 | 3.43 0.86 down from 2004 | 558 | 98% | $3,510 | ||
15Journal of Clinical MicrobiologyOAAmerican Society for Microbiology · United States | 1.65Q1 | 4.03 0.11 up from 2004 | 3,191 | 100% | — | ||
16Journal of Antimicrobial ChemotherapyOxford University Press · United Kingdom | 1.65Q1 | 4.00 0.33 up from 2004 | 1,346 | 35% | $3,784 | ||
17American Journal of Infection ControlElsevier BV · United States | 1.58Q1 | 3.24 0.63 down from 2004 | 291 | 11% | $3,360 | ||
18Journal of General VirologyMicrobiology Society · United Kingdom | 1.52Q1 | 3.55 0.47 down from 2004 | 1,167 | 11% | — | ||
19British Journal of Clinical PharmacologyWiley · United Kingdom | 1.49Q1 | 2.88 0.37 up from 2004 | 729 | 92% | $4,780 | ||
20AIDS and BehaviorSpringer Science+Business Media · Netherlands | 1.42Q1 | 2.52 1.26 up from 2004 | 119 | 8% | $4,590 | ||
21HIV MedicineWiley · United Kingdom | 1.42Q1 | 3.70 0.62 up from 2004 | 149 | 41% | $4,150 | ||
22Antiviral TherapyOASAGE Publishing · United Kingdom | 1.40Q1 | 4.03 0.23 up from 2004 | 233 | 59% | $2,800 | ||
23JAIDS Journal of Acquired Immune Deficiency SyndromesLippincott Williams & Wilkins · United States | 1.36Q1 | 3.77 0.36 up from 2004 | 1,099 | 8% | — | ||
24Infection Genetics and EvolutionOAElsevier BV · Netherlands | 1.36Q2 | 3.00 0.33 up from 2004 | 143 | 16% | $2,730 | ||
25Tropical Medicine & International HealthWiley · United Kingdom | 1.34Q2 | 2.46 0.19 up from 2004 | 469 | 48% | $3,400 | ||
26TuberculosisElsevier BV · United Kingdom | 1.33Q2 | 4.27 1.00 up from 2004 | 119 | 4% | $2,690 | ||
27Antiviral ResearchElsevier BV · Netherlands | 1.31Q2 | 3.49 0.02 up from 2004 | 283 | 18% | $4,160 | ||
28Journal of Medical MicrobiologyMicrobiology Society · United Kingdom | 1.29Q2 | 2.53 0.32 down from 2004 | 527 | 4% | — | ||
29Diagnostic Microbiology and Infectious DiseaseElsevier BV · United States | 1.29Q2 | 3.16 0.49 up from 2004 | 451 | 4% | $3,290 | ||
30AIDS CareTaylor & Francis · United Kingdom | 1.27Q2 | 2.01 0.05 up from 2004 | 275 | 9% | — | ||
31Virus ResearchOAElsevier BV · Netherlands | 1.27Q2 | 2.75 0.14 up from 2004 | 552 | 14% | $3,010 | ||
32Clinical Microbiology and InfectionElsevier BV · United Kingdom | 1.27Q2 | 2.76 0.63 up from 2004 | 616 | 96% | $3,780 | ||
33International Journal of Medical MicrobiologyOAElsevier BV · Germany | 1.21Q2 | 2.57 0.29 up from 2004 | 253 | 4% | $3,410 | ||
34Infection Control and Hospital EpidemiologyCambridge University Press · United Kingdom | 1.16Q2 | 1.17 0.12 down from 2004 | 1,235 | 15% | $3,550 | ||
35Journal of Medical VirologyWiley · United States | 1.13Q2 | 2.89 0.19 up from 2004 | 824 | 18% | $4,730 | ||
36Current HIV ResearchBentham Science Publishers · Netherlands | 1.13Q2 | 3.30 1.38 up from 2004 | 71 | 2% | — | ||
37Epidemiology and InfectionOACambridge University Press · United Kingdom | 1.11Q2 | 2.04 0.09 down from 2004 | 463 | 99% | $3,550 | ||
38Viral ImmunologyMary Ann Liebert, Inc. · United States | 1.11Q2 | 2.71 0.07 up from 2004 | 155 | 9% | — | ||
39ApmisWiley · United Kingdom | 1.10Q2 | 2.77 0.79 up from 2004 | 349 | 12% | $4,460 | ||
40BMC Infectious DiseasesOABioMed Central · United Kingdom | 1.01Q2 | 2.20 0.76 down from 2004 | 123 | 100% | $3,090 | ||
41Journal of Hospital InfectionElsevier BV · United Kingdom | 0.98Q2 | 2.31 0.10 up from 2004 | 607 | 11% | $4,000 | ||
42International Journal of STD & AIDSSAGE Publishing · United Kingdom | 0.97Q2 | 2.14 0.46 up from 2004 | 165 | 2% | $4,150 | ||
43FEMS Immunology & Medical MicrobiologyOxford University Press · Netherlands | 0.96Q2 | 2.39 0.48 up from 2004 | 511 | 39% | — | ||
44Medical Microbiology and ImmunologySpringer Science+Business Media · Germany | 0.95Q2 | 2.28 0.96 up from 2004 | 119 | 11% | $5,090 | ||
45InfectionSpringer Science+Business Media · Germany | 0.92Q2 | 1.99 0.41 up from 2004 | 235 | 13% | $4,790 | ||
46Expert Review of Anti-infective TherapyTaylor & Francis · United Kingdom | 0.91Q2 | 1.99 1.35 up from 2004 | 139 | 13% | — | ||
47Journal of Virological MethodsElsevier BV · Netherlands | 0.89Q3 | 2.10 0.08 up from 2004 | 638 | 14% | $3,210 | ||
48AIDS Patient Care and STDsMary Ann Liebert, Inc. · United States | 0.86Q3 | 2.20 0.44 up from 2004 | 212 | 6% | — | ||
49Filaria JournalSpringer Science+Business Media · United Kingdom | 0.81Q3 | 2.26 0.59 down from 2004 | 36 | 100% | — | ||
50HIV Clinical TrialsTaylor & Francis · United Kingdom | 0.79Q3 | 1.99 0.56 down from 2004 | 139 | 84% | — |
Subfields of Medicine, with Infectious Diseases highlighted.
- Surgery409
- Pulmonary and Respiratory Medicine172
- Public Health, Environmental and Occupational Health145
- Cardiology and Cardiovascular Medicine139
- Oncology120
- Infectious Diseases92
- Epidemiology91
- Psychiatry and Mental health87
- Radiology, Nuclear Medicine and Imaging81
- Neurology76
- Physiology72
- Endocrinology, Diabetes and Metabolism70
- Orthopedics and Sports Medicine54
- Pediatrics, Perinatology and Child Health52
- Dermatology49
- Hematology48
- Ophthalmology46
- Obstetrics and Gynecology41
- Rheumatology32
- Nephrology31
- Pharmacology31
- Complementary and alternative medicine25
- Reproductive Medicine25
- Emergency Medicine23
- Geriatrics and Gerontology19
- Otorhinolaryngology17
- Pathology and Forensic Medicine17
- Rehabilitation17
- Critical Care and Intensive Care Medicine13
- Immunology and Allergy12
- Hepatology9
- Genetics8
- Anesthesiology and Pain Medicine6
- Gastroenterology6
- Urology6
- Internal Medicine3
- Transplantation2
- Biochemistry1
- Family Practice1
- Anatomy0
- Health Informatics0
- Microbiology0
Journals
Citations made in 2005. Corpus-wide, 70.9% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
25 additional Infectious Diseases journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2002–2004, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2005. Publication window: 2002–2004. How these summaries are calculated
- Ranked journals
- 92
- Window papers (baseline)
- 28,008 +22.8% from indicator year 2002
- Median OJR
- 0.901 +9.6% from indicator year 2002
- Rising journals (2025)
- 48
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2002–2004 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 70 | 73 | 78 | 82 | 86 | 92 | 95 | 101 | 106 | 110 | 118 | 131 | 144 | 162 | 173 | 182 | 189 | 198 | 210 | 217 | 222 | 234 | 243 | 259 | 263 | 258 | |
| Window papers (baseline) | 18,375 | 21,167 | 22,805 | 24,640 | 25,208 | 28,008 | 31,333 | 35,063 | 38,170 | 42,272 | 46,364 | 49,515 | 52,080 | 54,445 | 58,513 | 62,728 | 67,259 | 69,548 | 70,742 | 70,658 | 72,743 | 100,768 | 135,954 | 162,915 | 153,103 | 130,899 | |
| Median OJR | 0.602 | 0.68 | 0.82 | 0.76 | 0.77 | 0.901 | 0.98 | 0.93 | 1.04 | 0.998 | 1.01 | 0.999 | 0.97 | 0.900 | 0.91 | 0.874 | 0.85 | 0.8699 | 0.8696 | 0.83 | 0.80 | 0.597 | 0.61 | 0.64 | 0.70 | 0.75 |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.